AAAAAA
Results:
1-13
|
Results: 13
Authors:
LIETZENMAYER R
GRESCHNIOK A
THELEN MH
DOHMEN BM
MULLERBERG M
MULLERSCHAUENBURG W
DITTMANN H
BULTMANN B
BARES R
Citation: R. Lietzenmayer et al., GLUCOSE-METABOLISM AND KI67 AS PROGNOSTIC PARAMETERS OF DIFFERENTIATED THYROID-CANCER (DTC), The Journal of nuclear medicine, 39(5), 1998, pp. 67-67
Authors:
DOHMEN BM
BOKEMEYER C
OECHSLE K
LIETZENMAYER R
PFANNENBERG AC
BARES R
Citation: Bm. Dohmen et al., PROGNOSTIC VALUE OF FDG-PET PERFORMED BEFORE HIGH-DOSE CHEMOTHERAPY IN GERM-CELL CANCER, The Journal of nuclear medicine, 39(5), 1998, pp. 256-256
Authors:
DOHMEN BM
BOKEMEYER C
OECHSLE K
LIETZENMAYER R
PFANNBERG AC
BARES R
Citation: Bm. Dohmen et al., ACCURACY OF FDG-PET IN CLASSIFICATION OF RESIDUAL TUMOR MASSES AFTER CHEMOTHERAPY OF GERM-CELL CANCER, The Journal of nuclear medicine, 39(5), 1998, pp. 257-257
Authors:
MULLERBERG M
HOFFMANN J
DAMANN F
LIETZENMAYER R
DOHMEN BM
SCHWENZER N
CLAUSSEN C
BARES R
Citation: M. Mullerberg et al., PREOPERATIVE LYMPH-NODE STAGING OF SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK - COMPARISON OF CT, MRI AND 18FDG-PET, The Journal of nuclear medicine, 39(5), 1998, pp. 480-480
EVALUATION OF TISSUE VIABILITY OF RESIDUAL OR RECURRENT MASSES IN HODGKINS-DISEASE BY [F-18] FDG-PET
Authors:
DITTMANN H
DOHMEN BM
SOKLER M
KOPP A
LIETZENMAYER R
MULLERBERG M
KANZ L
CLAUSSEN C
BARES R
Citation: H. Dittmann et al., EVALUATION OF TISSUE VIABILITY OF RESIDUAL OR RECURRENT MASSES IN HODGKINS-DISEASE BY [F-18] FDG-PET, The Journal of nuclear medicine, 39(5), 1998, pp. 581-581
Authors:
FEINE U
MULLERSCHAUENBURG W
LIETZENMAYER R
Citation: U. Feine et al., PET IMAGING OF RECURRENT MEDULLARY-THYROID CANCER, Nuklearmedizin, 36(3), 1997, pp. 156-156
Authors:
DOHMEN BM
BRUGGER W
LIETZENMAYER R
SOKLER M
KANZ L
BARES R
Citation: Bm. Dohmen et al., EVALUATION OF RESIDUAL OR RECURRENT MALIGNANT-LYMPHOMA BY FDG-PET, The Journal of nuclear medicine, 38(5), 1997, pp. 624-624
Authors:
THELEN MH
LIETZENMAYER R
BLAHETA HJ
BREUNINGER H
SOTLAR K
KOCH S
ESCHMANN SM
DOHMEN BM
BARES R
Citation: Mh. Thelen et al., LYMPHOSCINTIGRAPHY AND INTRAOPERATIVE SENTINEL NODE DETECTION IN MALIGNANT-MELANOMA - COMPARISON WITH HISTOLOGY AND POLYMERASE CHAIN-REACTION (PCR), The Journal of nuclear medicine, 38(5), 1997, pp. 997-997
Authors:
FEINE U
LIETZENMAYER R
HANKE JP
HELD J
WOHRLE H
MULLERSCHAUENBURG W
Citation: U. Feine et al., FLUORINE-18-FDG AND IODINE-131-IODIDE UPTAKE IN THYROID-CANCER, The Journal of nuclear medicine, 37(9), 1996, pp. 1468-1472
Authors:
LIETZENMAYER R
MULLERSCHAUENBURG W
FEINE U
BARES R
Citation: R. Lietzenmayer et al., [18-F]-FDG-WHOLE-BODY-PET FOR DETECTION OF RECURRENT THYROID-CANCER -RESULTS IN 36 PATIENTS, The Journal of nuclear medicine, 37(5), 1996, pp. 528-528
Authors:
LIETZENMAYER R
FEINE U
HELD J
KREISSIG I
STANOWSKY A
MULLERSCHAUENBURG W
BARES R
Citation: R. Lietzenmayer et al., DETECTION AND TREATMENT CONTROL OF OCULAR MELANOMA USING 18-FDG-PET -FIRST RESULTS, The Journal of nuclear medicine, 37(5), 1996, pp. 608-608
Authors:
HIRNLE P
FEINE U
SCHMIDT D
LIETZENMAYER R
Citation: P. Hirnle et al., DETECTION OF BREAST-CANCER LYMPH-NODE METASTASES WITH POSITRON EMISSION TOMOGRAPHY, Lymphology, 29, 1996, pp. 122-123
Authors:
FEINE U
LIETZENMAYER R
HANKE JP
WOHRLE H
MULLERSCHAUENBURG W
Citation: U. Feine et al., (18)FDG WHOLE-BODY PET IN DIFFERENTIATED THYROID-CARCINOMA - FLIPFLOPIN UPTAKE PATTERNS OF (18)FDG AND I-131, Nuklearmedizin, 34(4), 1995, pp. 127-134
Risultati:
1-13
|